D83
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: CVID Patients who have been treated in the Center for Chronic Immunodeficiency (CCI) in Freiburg since January 1, 2012/ Patient consent declaration/ Participation in the first study phase WoHL-CVID I
Exclusion criteria
Exclusion criteria: Patient with a very high disease burden and a short life expectancy or a permanently very bad general health condition. Not enough knowledge of the German language in spoken and written, strong cognitive restrictions.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of the effectiveness of the training developed in the first study phase.The primary endpoint is the change of the patient reported outcome "Health education literacy of patients" (HELP) between baseline (T0) and after four months (T1). | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Assessment of the satisfaction of the participants with the training. 2. Identify groups that are particularly benefiting by the training. | — |
Countries
Germany
Contacts
Centrum für Chronische Immundefizienz (CCI)am Zentrum für Translationale Zellforschung (ZTZ)Clinical Research Unit